Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma

31 May 2025

Abstract excerpt

Lung cancer is responsible for 2.21 million annual cancer cases and is the leading worldwide cause of cancer-related deaths. Specifically, lung adenocarcinoma (LUAD) is the most prevalent lung cancer subtype resulting from genetic causes; LUAD has a 15% patient survival rate due to it commonly being detected in its advanced stages. This study aimed to identify a novel biomarker signature of early-stage LUAD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40563443
DOI: 10.3390/biom15060803

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung AdenocarcinomaPMID 40563443Read ↗

The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformaticsSemantic proximity Read ↗

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and PrognosisSemantic proximity Read ↗

Seven-gene biomarkers reveal prognostic and immune signatures in lung adenocarcinomaSemantic proximity Read ↗

Identification key genes, key miRNAs and key transcription factors of lung adenocarcinomaSemantic proximity Read ↗

Identification of molecular markers associated with diagnosis and prognosis in lung adenocarcinoma by bioinformatics analysisSemantic proximity Read ↗

Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databasesSemantic proximity Read ↗

HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental ValidationSemantic proximity Read ↗

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity Read ↗

Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approachesSemantic proximity Read ↗

Identification and validation of two LUAD-development characteristic gene sets for diagnosing lung adenocarcinoma and predicting prognosisSemantic proximity Read ↗

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinomaSemantic proximity Read ↗

Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.